000 03522naa a22005177i 4500
001 UMUN-OA-20261005-MLS-045
003 local
005 20261005174905.0
006 m o d
007 cr||||||||||||
008 261005s2022 xx o u000 0 eng d
024 7 _a10.7150/thno.67184
_2doi
035 _a(local)EuropePMC:PMC8692915
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aXirui Chen
_eauthor.
245 1 0 _aTailoring noble metal nanoparticle designs to enable sensitive lateral flow immunoassay. /
_cXirui Chen; Lu Ding; Xiaolin Huang [and others].
264 1 _a[Place of publication not identified] :
_bIvyspring International Publisher,
_c2022.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aLateral flow immunoassay (LFIA) with gold nanoparticles (AuNPs) as signal reporters is a popular point-of-care diagnostic technique. However, given the weak absorbance of traditional 20-40 nm spherical AuNPs, their sensitivity is low, which greatly limits the wide application of AuNP-based LFIA. With the rapid advances in materials science and nanotechnology, the synthesis of noble metal nanoparticles (NMNPs) has enhanced physicochemical properties such as optical, plasmonic, catalytic, and multifunctional activity by simply engineering their physical parameters, including the size, shape, composition, and external structure. Using these engineered NMNPs as an alternative to traditional AuNPs, the sensitivity of LFIA has been significantly improved, thereby greatly expanding the working range and application scenarios of LFIA, particularly in trace analysis. Therefore, in this review, we will focus on the design of engineered NMNPs and their demonstration in improving LFIA. We highlight the strategies available for tailoring NMNP designs, the effect of NMNP engineering on their performance, and the working principle of each engineering design for enhancing LFIA. Finally, current challenges and future improvements in this field are briefly discussed.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aEngineering
650 4 _aNoble Metal Nanoparticles
650 4 _aLateral Flow Immunoassay
650 4 _aNanoparticle Design
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aimmunoassay
655 4 _aReview articles.
700 0 _aLu Ding
_eauthor.
700 0 _aXiaolin Huang
_eauthor.
700 0 _aYonghua Xiong
_eauthor.
773 0 _tTheranostics
_gVol. 12, no. 2, (2022), pages/article 574-602
_x1838-7640
856 4 0 _uhttps://europepmc.org/articles/PMC8692915
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC8692915
_qlocal
942 _n0
999 _c1187
_d1187